The SURPASS-1 trial demonstrated significant improvements in glycemic control and substantial reductions in body weight with all three doses of tirzepatide (5 mg, 10 mg, or 15 mg) compared to placebo over a 40-week period
Consider pre-loading syringes if your protocol calls for three or more injections per week
Ideal Candidates Patients for whom diet and exercise alone have not effectively helped them lose weight may be good candidates for GLP-1
In fact, studies show that GLP-1 receptor agonists may help people maintain an average weight loss of up to 17% of their initial body weight (Rubino, 2021)
"After months of preparation, we are proud to introduce our new California Gold Nutrition supplements specifically formulated to mitigate the adverse effects of GLP-1 therapy," said Emun Zabihi, CEO of iHerb
Call Options immediately so we may reschedule your appointment and get your medication shipped out ASAP